Federated Hermes, Inc.

Equities

FHI

US3142111034

Investment Management & Fund Operators

Real-time Estimate Cboe BZX 01:22:27 2024-04-26 pm EDT 5-day change 1st Jan Change
33.2 USD -2.78% Intraday chart for Federated Hermes, Inc. -5.70% -1.71%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Federated Hermes, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Earnings Flash (FHI) FEDERATED HERMES Posts Q1 EPS $0.89 MT
Earnings Flash (FHI) FEDERATED HERMES Posts Q1 Revenue $396.4M MT
Federated Hermes, Inc. Declares Special Dividend, Payable on May 15, 2024 CI
Federated Hermes, Inc. Declares Quarterly Dividend, Payable on May 15, 2024 CI
Transcript : Federated Hermes, Inc. - Shareholder/Analyst Call
UBS Adjusts Federated Hermes Price Target to $39 From $37, Maintains Neutral Rating MT
EMEA Morning Briefing : Stocks Seen Lower; Investors Await Fresh Data for Rate Cut Cues DJ
EMEA Morning Briefing : Stocks May Ease After Record Highs DJ
Policy uncertainty drives investors into US medium-term bond funds RE
AstraZeneca AB entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc. for $1.8 billion. CI
Regulus Therapeutics Inc. announced that it has received $100.000267 million in funding from a group of investors CI
Analysis-Property titans seek clues in Cannes for market turnaround RE
Federated Hermes Premier Municipal Income Fund Declares Dividend, Payable on April 1, 2024 CI
Regulus Therapeutics Inc. announced that it expects to receive $100.000267 million in funding from a group of investors CI
Federated Hermes Insider Sold Shares Worth $500,327, According to a Recent SEC Filing MT
Xcelerate Pte Ltd announced that it has received $25 million in funding from Federated Hermes, Inc., Altair Capital Advisors Pte Ltd, Exacta Capital Partners, and other investors CI
Macquarie plans to cut stake in UK's Cadent - FT RE
Hyundai seeks expansion, higher valuation with India IPO RE
Federated Hermes Insider Sold Shares Worth $3,200,014, According to a Recent SEC Filing MT
Deutsche Bank Adjusts Federated Hermes Price Target to $39 From $38, Maintains Buy Rating MT
RBC Lifts Price Target on Federated Hermes to $37 From $36, Keeps Sector Perform Rating MT
Transcript : Federated Hermes, Inc., Q4 2023 Earnings Call, Jan 26, 2024
Federated Hermes Q4 Earnings, Revenue Rise -- Shares Jump MT
Earnings Flash (FHI) FEDERATED HERMES Reports Q4 EPS $0.96 MT
Chart Federated Hermes, Inc.
More charts
Federated Hermes, Inc. is an investment management company. The Company operates through a single segment, being the investment management business. It sponsors, markets and provides investment-related services to various investment products, including sponsored investment companies and other funds (Federated Hermes Funds); and Separate Accounts, which include separately managed accounts (SMAs), institutional accounts, sub-advised funds and other managed products in both domestic and international markets. In addition, it markets and provides stewardship and real estate development services to various domestic and international companies. The Company provides investment advisory services to approximately 180 Federated Hermes Funds. It markets these funds to institutional customers and banks, broker/dealers and other financial intermediaries who use them to meet the needs of customers and/or clients, including, among others, retail investors, corporations and retirement plans.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
34.15 USD
Average target price
39.38 USD
Spread / Average Target
+15.30%
Consensus
  1. Stock Market
  2. Equities
  3. FHI Stock
  4. News Federated Hermes, Inc.
  5. Federated Hermes : JP Morgan Adjusts Federated Hermes' Price Target to $33 from $29, Keeps Neutral Rating